Dear Editor,
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of the pandemic coronavirus disease 2019 (COVID-19), which has infected nearly 90 million people and resulted in 2 million human deaths by the end of the year 2020. SARS-CoV-2 can survive in aerosols or on the surfaces of various materials for up to 72 h (Ong et al. 2020; van Doremalen et al. 2020). In China, although the human-to-human transmission pathway is under well control, the fomite transmission pathway now accounts for a significant fraction of new infection cases. Therefore, environmental disinfection of public areas and workspaces potentially contaminated by SARS-CoV-2 is an important measure to control the spread of COVID-19 by fomite transmission. A disinfectant that is safe and readily available at a low cost is urgently needed to meet environmental disinfection requirements.
Ozone is a highly reactive oxidant gas composed of three oxygen atoms and widely used in industry and medical waste disinfection (Elvis and Ekta 2011; Smithet al. 2017). A broad spectrum of viral pathogens (Sato et al. 1990), including SARS-CoV (Zhang et al. 2004), can be effectively inactivated by ozone treatment. The purpose of this study was to evaluate whether ozone water is a potential disinfectant to eliminate the environmental contamination of SARS-CoV-2.
The scheme of the experiment is showing in Fig. 1A. Briefly, 50 μL viral supernatant was incubated with 225 μL ozone water or unozonated tap water. After different incubation periods, the disinfection reaction was terminated by adding 225 μL stopping buffer (complete culture media with 5 g/L sodium thiosulfate). The resulting mixture was then inoculated into Vero E6 cells. At 24 and 48 h post-infection (hpi), the genomic RNA of secreted viruses was quantified by reverse transcription-polymerase chain reaction (qRT-PCR) assay using a Taqman probe targeting the N gene of SARS-CoV-2 (Primers: 5′-TAACCAGAATGGAGAACGCAGTG-3′/5′-TGAGTGAGAGCGGTGAACCAAGAC-3′; Probe:5′-ATCAAAACAACGTCGGCCCCAAGGT-3′/HEX + BHQ2) (Zheng et al. 2020). In parallel, the viral titers were determined by viral plaque assay at 96 hpi.
A recent report showed that the Ct values of SARS-CoV-2 from various contaminated materials were generally between 25 to 32 (Ong et al. 2020). Based on this information and the observed correlation between Ct values and plaque-forming units (PFU) of SARS-CoV-2 (Uhteg et al. 2020), we estimated the viral PFU from common environmental contamination is approximately ranging from 0 to 102 PFU/mL. To check whether ozone water can inactivate environmental SARS-CoV-2 contamination, we diluted SARS-CoV-2 stock to 4.0 × 103 PFU/mL, a 10-times higher PFU than the estimated upper limit of environmental virus contamination. The viral solution was incubated with ozone water (36 mg/L ozone) for 0, 1, 5, or 10 min, respectively. No viral genomic RNA or viral plaques were detected after ozone water treatment for 1 min (Fig. 1B, 1C), suggesting that ozone water could effectively inactivate SARS-CoV-2 in less than 1 min. When viral PFU increased to 4.0 × 104 PFU/mL, ozone water (36 mg/L ozone) could still fully inactivate 50 μL viral solution in less than 1 min compared to tap water-treatment (Fig. 1D, 1E).
To further determine the minimal ozone water concentration required to inactivate SARS-CoV-2, ozone water was serially diluted and incubated with the viral solution (4.0 × 104 PFU/mL) for 1 min to inactivate the virus. We found that SARS-CoV-2 was fully inactivated by ozone water harboring 36 mg/L and 18 mg/L ozone, as neither viral genomic RNA nor viral plaques were detected (Fig. 1F, 1G). However, when ozone concentration was below 9 mg/L in ozone water, the genomic RNA copy number of SARS-CoV-2 was detected in the range of 4.0 × 103 and 5.0 × 105 copies/mL (Fig. 1F), and the virus titer was between 1.0 × 102 and 7.0 × 102 PFU/mL (Fig. 1G). The above results implied that ozone concentration above 18 mg/L could effectively eliminate SARS-CoV-2 infectivity within 1 min.
In summary, we demonstrated that ozone water is an effective disinfectant in the elimination of SARS-CoV-2. Compared to the traditional chemical disinfectant, ozone water offers several advantages. Firstly, ozone water is eco-friendly and will not cause a secondary hazard to the environment after its administration. The residual ozone in the water can be decomposed rapidly and converted to oxygen within a short period (typically within 30 min) under natural conditions. This feature is highly valuable for food disinfection. Secondly, an ozone water generator's price is usually as low as 8,000 Yuan in China, which can convert tons of tap water into ozone water in less than 30 min. Such ease of production at a low cost makes ozone water far superior to traditional chemical disinfectants, particularly when a large amount of disinfectant is needed to disinfect a large area, e.g., a cold warehouse for imported food, which is usually contaminated with SARS-CoV-2. In contrast, traditional disinfectants like ethanol, the price is usually over 10,000 Yuan per ton in China. Thirdly, SARS-CoV-2 can be inactivated by ozone water within 1 min, which is very efficient. In addition to ozone water, other studies also showed that ozone gas is highly effective in eliminating SARS-CoV-2 (Criscuolo et al. 2021). In our opinion, ozone gas has a considerable advantage in disinfecting virus contamination in the aerosol, whereas ozone water is more effective in surface disinfection simply by immersing contaminated material in the ozone water. However, both forms of ozone must be administrated with caution to prevent lung injury due to the inhalation of ozone gas.
Although further study is needed to evaluate the disinfection efficacy of ozone water in real-world conditions, our study provides the first step in the proof of principle before applying ozone water in environmental settings.
Acknowledgements
This work was supported by National Key Research and Development Program (2020YFC0846200). We acknowledge Mr. Hao Tang and Mr. Jun Liu for their assistance in BSL-3 laboratory work.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Animal and Human Rights Statement
This article does not contain any studies with human or animal subjects performed by any of the authors.
Contributor Information
Jun Ma, Email: majun@jit.edu.cn.
Wuxiang Guan, Email: guanwx@wh.iov.cn.
Rongjuan Pei, Email: rongjuan_pei@wh.iov.cn.
Yun Wang, Email: wangyun@wh.iov.cn.
References
- Criscuolo E, Diotti RA, Ferrarese R, Alippi C, Viscardi G, Signorelli C, Mancini N, Clementi M, Clementi N. Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials. Emerg Microbes Infect. 2021;10:206–210. doi: 10.1080/22221751.2021.1872354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. 2011;2:66–70. doi: 10.4103/0976-9668.82319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323:1610–1612. doi: 10.1001/jama.2020.3227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sato H, Wananabe Y, Miyata H. Virucidal effect of ozone treatment of laboratory animal viruses. Jikken Dobutsu. 1990;39:223–229. doi: 10.1538/expanim1978.39.2_223. [DOI] [PubMed] [Google Scholar]
- Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7:212–219. doi: 10.4103/2045-9912.215752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uhteg K, Jarrett J, Richards M, Howard C, Morehead E, Geahr M, Gluck L, Hanlon A, Ellis B, Kaur H, Simner P, Carroll KC, Mostafa HH. Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays. J Clin Virol. 2020;127:104384. doi: 10.1016/j.jcv.2020.104384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567. doi: 10.1056/NEJMc2004973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang JM, Zheng CY, Xiao GF, Zhou YQ, Gao R. Examination of the efficacy of ozone solution disinfectant in in-activating SARS virus. Chin J Disinfect. 2004;21:27–28. [Google Scholar]
- Zheng X, Wang H, Su Z, Li W, Yang D, Deng F, Chen J. Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China. J Infect. 2020;81:e128–e129. doi: 10.1016/j.jinf.2020.05.041. [DOI] [PMC free article] [PubMed] [Google Scholar]